Press Release
Issa, Grassley Report on FDA Employee Monitoring Finds Agency Still Lacks Adequate Whistleblower Protections
WASHINGTON – Today, House Oversight and Government Reform Committee Chairman Darrell Issa, R-Calif., and Senate Judiciary Committee Ranking Member Chuck Grassley, R-Iowa, released a joint report on the U.S. Food and Drug Administration (FDA)’s highly-invasive surveillance program that monitored employees who contacted Congress and the media with concerns about FDA’s medical device approval process.
In April 2010, the FDA initiated a surveillance ...